Events

Meet us at ISPOR Europe 2025 this November as we join the global conversation on real-world evidence and health economics. Information about our booth location and additional involvement will be announced in due course!

We'll be at ESMO 2025 in Berlin — stay tuned for updates on our continued contributions to oncology research.

We are thrilled to announce our participation as a Gold Sponsor at the 2025 OHDSI Europe Symposium, taking place from July 5-7. This year, the symposium makes its debut outside its usual Rotterdam setting, in the historic "Old Prison" building of Hasselt University, Belgium. We look forward engaging with fellow health tech innovators, hospitals, and life sciences organizations to shape the future of health data science.

On 26 March, at the European Lung Cancer Congress, Dr. Decoster (UZ Brussels) will be presenting the joint poster "Real-World Biomarker Testing and Treatment Patterns in Belgian Lung Cancer Patients: Insights from the AIBED Study".

On January 31st, at the BSMO 2025 Congress, Dr. Nuytemans (AZ Groeninge) unveiled the insights from a Belgian multi-center real-world study in breast cancer patients.

We will be attending ISPOR Europe 2024 in Barcelona. Meet our dream team at booth 1126, and discover real-world data use cases in oncology, cardiology and psychiatry, learn more about our European hospital data network and explore the potential of our state-of-the-art proprietary NLP pipeline.

Join us at the ESMO Congress 2024 from 13-17 September in Barcelona, and discover our 2 posters on (i) the real-world usage and adverse events of immune checkpoint inhibitors, and (ii) cardiovascular toxicities in real-world cancer patients treated with immune checkpoint inhibitors.

We are attending the 10th annual OHDSI Global symposium.

We will be attending the OHDSI UK symposium in London!

Meet us at OHDSI Europe 2024 workshops and symposium! On 3 June, Dr. Annelies Verbiest (UZA) and Clara L. Oeste (LynxCare) will provide insights into our Belgian oncology research network and present the initial results from a study into Lung Cancer patients treated with immune checkpoint inhibitors (ICI).

On 28-29 May, catch Peter Oledzki (VP Business Development Europe) at the Digi-Tech Pharma & AI 2024 conference in London. Reach out if you are attending and wish to connect!

On 8 May, catch us in Heidelberg, where we will be presenting on how we have harmonized Real-World Data Networks with Common Data Models for pan-cancer immune checkpoint inhibitor insights in a multicenter study

We will be attending ISPOR 2024 in Atlanta, where we will be presenting our poster on 'Creating European Federated Data Networks with Common Data Models to Conduct Real-World Evidence Observational Studies in Oncology'.

From 16-18 April, we will be attending the Reuters Pharma Congress. We look forward to connecting!

From 20-23 March, we will be attending the European Lung Cancer Congress. Don't miss out on our poster on 'Real-World Evidence of Immune Checkpoint Inhibitor Treatment in Lung Cancer Patients from a Belgian Multicenter Study'.

ESMO Immuno-Oncology 2023 will take place from 6-8 December in Geneva. Don't miss out on the poster presentation of Dr. Verbiest (UZA): "Real-World Insights on Pan-Cancer Immune Checkpoint Inhibitor Treatment: Initial Findings of a Belgian Multicenter Study"

The countdown to ISPOR Europe can begin! Meet us at booth C3-068, and come listen to our poster presentation on 14 November, 12h30-13h30.

We are happy to announce the 5th edition of Big Data 4 Health! Join us for an engaging and dynamic evening that will serve as a platform to share know-how and experiences in the realm of big data for research and patient care. 

Meet us at ESC Congress in Amsterdam, where we join forces to protect the heart and create the future of cardiology. Contact us to schedule a meeting onsite or to have a quick chat over coffee/tea.

The Molecular Analysis for Precision Oncology Congress (MAP) 2023 will take place on 4 and 5 October 2023 in Paris, France. Watch our for our joint poster presentation with UMCG: "Identifying EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC) Patients from the Netherlands through Automatic Data Processing".

Learn how you can gain access to deep insights from highly detailed RWD. Representative datasets of diverse European patient populations, to push your research studies forward faster and with the level of quality necessary to help improve the patient journey.

Come find our exhibit at the European OHDSI symposium on July 3rd in Rotterdam! We look forward to sharing how we help hospitals unlock their structured and unstructured data, harmonize them to the OMOP CDM, and set up clinical grade data warehouses to facilitate research and collaboration.

Meet us there together with our partner PSIH Group from May 23 to 25! Ready to innovate? Prepare your hospital for the France 2030 plan and the European Health Data Space. Find us at Stand L60 and discover how we can help address your hospital's challenges of today and tomorrow! On 23 May, at 12h15, we will be presenting our solution dedicated to healthcare data warehouses on the "command center" stage.

Meet us at the HIMSS conference in Chicago, there where the global healthcare and technology spaces unite. Contact us to schedule a meeting onsite or to have a quick chat over coffee/tea on the banks of Lake Michigan.

On 25 April, we will be presenting at the DMEA, one of Europe's most important events for Digital Health. Clara L. Oeste, Senior Medical Writer, will discuss automated data extraction from electronic health records using NLP and federated OMOP databases: lessons learned in heart failure.

At this conference, organized by the European Association for Cancer Research (EACR), the latest advances in the field of immuno-oncology, from the basic science to clinical studies, will be covered. Meet us at stand 3, and attend our spotlight session on Wednesday, 10 May, from 2.45 - 3.05pm!

The ESC Heart Failure congress, world's leading event on heart failure, will cover the entire spectrum of heart failure, from prevention to diagnosis and treatment. On 21 May, Dr. Vanderheyden (OLV Hospital) will be presenting our joint study on the use of a systematic framework to diagnose aTTR-CM in a real-world heart failure population.

RARE 2022 will follow on from the success of its predecessors, continuing to address the challenges of Rare Diseases. During the conference, LynxCare will be presenting our hTTR use case.

On 24 November 2022, pharma.be organizes a networking event for all its members. During this event in the shape of a trade fair, all partners and SMEs have the possibility to set up a company booth and participate to speed dating with pharma.be members on specific topics (real-world data & digital health and market access). Meet LynxCare there!